Patient-Centered Priorities for Improving Medication Management and Adherence
For which topic were research priorities identified?
medication management and adherence
In which location was the research priority setting conducted?
North America - USA
Why was it conducted at all?
The potential for patient-centered approaches to improve medication outcomes for people with chronic illness prompted a diverse group of therapeutics researchers funded by the Agency for Healthcare Research and Quality (AHRQ) - the Centers for Education and Research on Therapeutics (CERTs) - to convene a two-day workshop in October, 2012 to evaluate how medication adherence interventions could be more patient-centered. An early decision was made to engage other key stakeholders to collaboratively identify and prioritize research and practice needs related to medication adherence.
What was the objective?
to identify and prioritize opportunities to advance patient-centered medical management by convening diverse stakeholders involved in prescribing and/or medication taking
What was the outcome?
a ranking list of 10 research topics
How long did the research prioritization take?
No information provided.
Which methods were used to identify research priorities?
How were the priorities for research identified exactly?
Step 1: workshop: presentations and group discussions followed by voting to establish research and practice priorities: presentations on review of current literature, review of social science research and panel discussion, small group discussions, participants were asked to list their primary perspective as stakeholders, creating list of all discussion topics, grouping into similar themes, voting with stickers: participants were asked to place total of six votes on the agenda items they prioritized
Which stakeholders took part?
Patients, caregivers, providers, product makers, payers, purchasers of healthcare, research funders, policymakers, and researchers. 28 participants.
How were stakeholders recruited?
The steering group invited 23 thought leaders representing the following constituencies: patients/patient advocates, caregivers, providers, payers, researchers, funders, product makers, policymakers/consumer advocates, and purchasers of health care.
Were stakeholders actively involved or did they just participate?
Stakeholders not only participated but were also actively involved in the research prioritization process: They were part of a steering group. The steering group consisted of 13 members: 11 CERTs investigators who have worked on medication adherence from a variety of scientific perspectives (medicine, pharmacy, informatics, epidemiology, and social science), 2 patient representatives who have personal and advocacy experience with arthritis and juvenile diabetes. The members developed definitions of PCMM and its components, and used PCMM to guide a literature review as well as the workshop's agenda and prioritization process, and also identified potential workshop participants.